The biobanking market in North America is experiencing substantial growth, driven by an increasing demand for personalized medicine, advancements in genomics, and the rising prevalence of chronic diseases. Valued at USD 1.1 billion in 2024, the market is projected to expand at a compound annual growth rate (CAGR) of 6.31% from 2025 to 2034. By the end of the forecast period, the market is...